Screening of Psychoactive Substances Use and Anxio-depressive Disorders in Consultation for HIV Pre-exposure Prophylaxis
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 237
- Locations
- 5
- Primary Endpoint
- Estimate the acceptability and the impact on the management of a systematic identification of the use of psychoactive substances and / or anxio-depressive disorders by self-questionnaire in PrEP consultants
Study Overview
Brief Summary
HIV pre-exposure prophylaxis (PrEP) with Truvada®, a combination of two antiretrovirals (tenofovir & emtricitabine) is a prevention strategy for HIV-negative people at high risk of acquiring HIV. PrEP has thus been integrated as a new tool to significantly reduce the risk of HIV infection, especially among men who have sex with men (MSM). Since its introduction, an increase in sexually transmitted infections (STIs) has been observed, particularly in relation to the use of psychoactive substances in a sexual context (Chemsex).
In this context, the description and evaluation of these practices seem necessary, as well as the impact on the risk of addiction and mental health.
Detailed Description
Interventional, multi-center pilot study, including all subjects aged 18 years or older presenting in consultation for a PrEP renewal.
The newsletter and a self-questionnaire will be systematically given in the waiting room to any PrEP consultant to evaluate the consumption of psychoactive substances (ASSIST questionnaire) and to identify anxio-depressive disorders (HAD questionnaire - Hospital Anxiety and Depression). scale). After consent, the answers will be discussed with the doctor during the consultation for appropriate care, including a referral to a psychiatrist and / or addictologist if necessary.
The duration of the inclusions will be 6 months and the number of patients to include is 250.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Other
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Subject aged over 18,
- •Subject seen in consultation in one of the centers of the study for a renewal of the Prep
- •Subject having agreed to participate in the study
Exclusion Criteria
- •Subject not speaking French / illiterate
Arms & Interventions
Single Arm
To estimate the acceptability and the impact on the management of a systematic identification of the use of psychoactive substances and / or anxio-depressive disorders by self-questionnaire.
Intervention: self-administered questionnaire (Other)
Outcomes
Primary Outcomes
Estimate the acceptability and the impact on the management of a systematic identification of the use of psychoactive substances and / or anxio-depressive disorders by self-questionnaire in PrEP consultants
Time Frame: 1 year after the study start date
Secondary Outcomes
No secondary outcomes reported